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INTRODUCTION 
Mucodhesion is a promising approach in the design of 
drug delivery systems to prolong the residence time of the 
dosage form the site of application or absorption and to 
facilitate intimate contact of the dosage form with the 
underlying absorption surface to improve and enhance the 
bioavailability of drugs1. Several studies reported 
mucodhesive drug delivery systems in the form of tablet, 
films, patches and gels for oral, buccal, nasal, occular and 
topical routes. 
Levofloxacin hydrochloride is a fluoroquinolone 
antibacterial drug, which is used in the various kinds of 
infections like urinary tract infections, gonorrhoea 
vaginitis etc2. It has very bitter taste and is readily soluble 
in the gastric pH due to the formations of salt.  The drug is 
also reported to have poor stability at elevated 
temperatures and exposure to sunlight, due to the ring 
opening and formation of ethylene diamine and 
formamide derivative 3. To over come with these 
problems, mucoadhesive microspheres of Levofloxacin 
were formulated using Sodium Alginate, Sodium 
Carboxymethyl Cellulose and Carbopol-940 polymers. 
These mucoadhesive polymers in the microspheres 
prolong the residence time of the dosage form in the 
gastrointestinal tract and hence are more suitable as matrix 
material for oral controlled release4.  
MATERIALS AND METHODS 
Levofloxacin hydrochloride was a gift sample from Cipla 
Ltd. Mumbai. Sodium Carboxymethyl Cellulose (1500-
400cps) was procured from Central Drug House, Mumbai. 
Carbopol-940 and Sodium Alginte was procured from 
Loba Chemie, Mumbai. Light liquid paraffin and Span-20 
were procured from commercial sources. All other 
reagents used were of analytical grade. 
Preparation of mucoadhesive microspheres: 
Microspheres were prepared by the water-in-oil (w/o) 
emulsification solvent evaporation technique. The model 
drug was dissolved in each polymeric aqueous solutions. 
The solutions were poured into 200 g of mineral oil 
containing 0.5% span -20 as an emulsifying agent. The 
aqueous phase was emulsified into the oily phase by 
stirring the system in a 500 ml beaker. Constant stirring at 
2000 rpm was carried out using mechanical stirrer (Remi, 
Model No.FTQ 124A). The beaker and its content were 
heated by an on the hot plate at 80 oC. Stirring and heating 
were maintained for 4.5 h until the aqueous phase was 
completely removed by evaporation. The light mineral oil 
was decanted and collected microspheres were washed 
three times with 100 ml aliquots of n-hexane, filtered 
through Whatman filter paper, dried in an oven at 50 oC 
for 2 h and stored in a desiccator at room temperature. 
Microspheres were prepared using Sodium Alginate, 
Sodium Carboxymethyl Cellulose and Carbopol-940 
polymers5. Compositions of formulation(s) are shown in 
Table 1.  
Drug content 
Levofloxacin content in the microspheres was estimated 
by a UV Spectrophotometric (Thermospectronic Model 
No.156) method based on the measurement of absorbance 
at 280 nm in distilled water. Microspheres equivalent to 
50 mg were weighed and added in 100 ml of distilled 
water. The volumetric flask was stirred continuously for 
24 h on a magnetic stirrer. Dilutions of above solutions 
were made suitably and measured for the drug content.  
Particle size: 
Particle size analysis was performed with the help of 
optical microscopy for all the formulations. 
In-Vitro Drug Release Study: 
Release of Levofloxacin HCI from the microspheres was 
studied in distilled water using USP XXIII Six station 
dissolution test apparatus (Thermospectronic Model 
No.156) with rotating basket at 100 rpm and at 37 
o
C. 
For each formulation, Microspheres equivalents to 100 mg 
of Levofloxacin were filled in empty capsule shells. One 
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capsule was used in each test and placed in the basket. 
Samples of dissolution fluid were withdrawn at different 
intervals, filtered and diluted suitably and then analyzed 
spectrophotometrically at 280 nm.   
(Fig.1, 2) show the graphical representation of in-vitro 
release profile from the formulations6. 
In –Vitro Test for  Mucoadhesion: 
The mucoadhesion property of the microspheres was 
evaluated by a modified in-vitro wash off test method. 
Pieces of the intestinal mucosa (3 cm x 1 cm) were 
mounted on to glass rods (4 cm x 1 cm) and placed in the 
tubes of USP Tablet disintegrating test apparatus. 50 
microspheres were spread on to each wet rinsed pieces of 
intestinal mucosa in distilled water7. The tissue specimen 
was given a slow regular up and down movement in the 
test fluid at 37 oC, up to 3.5 h, after each half a hour the 
machine was stopped and the number of microspheres 
adhering on to the tissue were counted by using convex 
hand lens. 
Stability Studies 
Microspheres formulations were stored at three different 
temperatures of refrigerated, at room temperature and at 
45 0C for 42 days8. After six week of the storage of the 
microspheres Levofloxacin was analyzed in consecutive 
order for the drug content spectrophotometrically at 280 
nm. Data of stability studies are shown graphicaly at 
different temperatures respectively. 
RESULT AND DISCUSSION 
Emulsion Solvent Evaporation Method using Sodium 
Carbooxymethyl Cellulose, Sodium Alginate and 
Carbopol-940 prepared the Mucoadhesive microspheres of 
Levofloxacin hydrochloride. Microspheres were designed 
using different ratios of the polymers as shown in Table 
given below 
Table 1: Composition of Mucoadhesive Microspheres 
Ingredient (g) F1 F2 F3 F4 F5 F6 
Drug (LevofloxacinHCl) 1 1 1 1 1 1 
Carbopol-940 - 1 - 0.5 - 0.5 
Sodium Carboxymethyl Cellulose 1 - - 0.5 0.5 - 
Sodium Alginate - - 1 - 0.5 0.5 
 
Table 2: Drug Content in different Formulations 
Formulations Theoretical loading (mg) Practical yield (mg) % Drug loading 
F1 50 32 64 + 1.50 
F2 50 38 76 + 2.50 
F3 50 26 52 + 3.40 
F4 50 37 74 + 2.40 
F5 50 29 58 + 2.95 
F6 50 25 50 + 4.5 
 
Table 2 shows drug content in all different Formulations 
were estimated by UV Spectrophotometric method, Percent 
loading efficiency were found in the range of 50-76 %.  
Formulation F2 containing carbopol-940 showed maximum 
percent loading of drug up to 76%. Formulation F6 
containing carbopol-940 / Sodium Alginate showed less 
percent loading of drug as compared to Formulation F2. 
Rank order of Percent loading was found to be as followed. 
F2 > F4 > F1 > F5 > F3 > F6. 
 
Particle size analysis of different formulations was done by 
optical microscopy. The average particle size was found to 
be in the range of 27.9 m - 35.75 m. F2 showed the least 
particle size of 27.9 m which is due to spherical nature of 
microspheres as showed by the SEM.  Sodium alginate 
showed the largest particle size of 35.75 m, due to the 
irregular nature of the microspheres, confirmed by SEM.   
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In-vitro release studies of all the formulations containing 
drug were performed in distilled water at 280 nm. It was 
found that the drug release from the Formulations were 
distinguishably different for the different polymers used in 
the Formulations. After the end of 8 h the release were 
found to be 91.26, 84.14, 43.39, 77.86, 57.07 and 76.84 
percent of formulations F1, F2, F3, F4, F5 and F6 respectively 
.  Formulation F1 containing SCMC showed the maximum 
release after the 8h and due to high swelling property of 
SCMC. While Sodium Alginate microspheres (F3) showed 
less drug release pattern after 8h due to less swelling 
action and irregular surface as compared to SCMC  
 
Higuchi plots were plotted for the formulations to 
determine the mechanism of drug release pattern fig 2 
shows the graphical representation of cumulative 
percentage drug release versus square root of time for all 
the formulations. These Higuchi’s Plots were found to be 
linear with correlation coefficient values of 0.9977, 
0.9724, 0.9799, 0.9914, 0.9915, 0.9882 for formulation F1, 
F2, F3, F4, F5 and F6 respectively. The linearity indicated 
that the drug release from the microspheres followed the 
matrix diffusion process. 
The plots of log cumulative percent drug retained versus 
time were found to be linear for all the formulations  his 
linearity indicates that the release of Levofloxacin from 
the microspheres have obeyed first order kinetics films 
might have followed first order kinetics. The correlation 
coefficient values were found to be -0.9770, -0.9454, -
0.9915, -0.9969, -0.9906, -0.9867 for formulation F1, F2, 
F3, F4, F5 and F6 respectively. It shows that data are in 
good correlation. Negative values of the correlation 
coefficient indicate negative slope for the plot. 
To assess the mucoadhesivity of the microspheres in-vitro 
wash off test was performed for all the formulations. At 
the end of 3.5 h Percent mucoadhesivity was found to be 
30, 16, 4, 10, 10, 4 for formulation F1, F2, F3, F4, F5 and F6 
respectively Table 3.  
Table 3: Results of In-Vitro Wash Off Test to Assess Mucoadhesive Property of the Microspheres 
Formulations Percent of Microspheres Adhering to Tissue at 6 times(min) in Distilled Water 
 30 60 90 120 150 180 210 
F1 86+2.54 70  +1.45 62  +0.97 56  +1.67 40  +1.35 36  +2.21 30+0.67 
F2 84+0.98 60  +1.24  40  +1.67 36  +1.64 26  +0.99 20  +1.08 16+1.90 
F3 80+ 1.45 56  +1.58 49  +0.64 32  +1.45 24  +2.02 10  +1.02 4+0.57 
F4 64+0.97 62  +1.24 46  +2.05 32  +1.34 24  +0.97 12  +0.66 10 +1.02 
F5 90+2.25 78  +1.65 64  +0.99 54  +1.86 20  +1.05 10  +0.64 10 +0.63 
F6 6 +1.23 44  +1.54 40  +1.02 30  +2.34 20  +2.04 8    +0.65 4 + 1.02 
 
Formulation F1 showed the highest percent mucoadhesion. 
The greater mucoadhesivity of the SCMC microspheres 
were due to anionic nature of the polymer, and sodium 
alginate showed the lowest percent mucoadhesion due to 
the irregular surface microspheres prepared by it. The rank 
order of mucoadhesion for the formulations were as found 
to be F1>F2  >F4 >F5 > F6 > F3  .The mucoadhesion profile 
of the formulations is depicted in  for the study period of 
3.5 h 
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Fig. 3 : Log Cumulative Percent Drug Retained in 
Different Formulations
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The stability studies of formulations were performed at 
three different temperature (refrigerated temperature, 
room temperature and 45 0C) for six week after 7, 14, 
21`, 28, 35 and 42 day of storage the drugs content in the 
microspheres were determined. Fig.4,5 and 6  
It was found that at refrigerated temperature 
microspheres are stable as compared that in room 
temperature and 45 0C. Microspheres showed maximum 
loss of drug content at 45 0C due to the enhanced rate of 
degradation of Levofloxacin at elevated temperature. It 
was concluded that incorporation of drug into the 
polymeric matrix of microspheres improved the stability 
of the drug. Formulation F1 showed the best stability 
profile at refrigerated and at room temperature while at 
elevated temperature decrease in the stability was 
observed. It was found that the formulation F2, F3 and F5 
showed the good stability profile as compared to other 
formulations at the same conditions. 
Among the mucoadhesive microspheres of Levofloxacin 
hydrochloride prepared using SCMC, sodium Alginate 
and Carbopol-940 polymers, the formulations F1 and F2 
containing SCMC and CP-940 showed reproducible 
results and the best mucoadhesive profile with good 
surface morphology. Formulation F2 (Carbopol-940), F3 
(Sodium alginate) and F5 (SCMC / Sodium alginate) 
microspheres showed the optimum, sustained release 
pattern as well as the good stability profile. 
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CONCLUSION 
Mucoadhesive microspheres of Levofloxacin 
hydrochloride were designed using different polymers. 
Microspheres showed maximum loss of drug content at 
45 0C due to the enhanced rate of degradation of 
Levofloxacin at elevated temperature. It was concluded 
that incorporation of drug into the polymeric matrix of 
microspheres improved the stability of the drug. 
Formulation F1 showed the best stability profile at 
refrigerated and at room temperature while at elevated 
temperature decrease in the stability was observed. It was 
found that the formulation F2, F3 and F5 showed the good 
stability profile as compared to other formulations at the 
same conditions. Further studies can be performed as in-
vivo drug release in animals in future. 
. 
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